DEINOVE advances first ingredient to commercial launch


In France, industrial biotechnology firm DEINOVE is set to commence production of its first carotenoid for cosmetics and nutrition applications. DEINOVE’s fermentation platform has demonstrated an optimized process using Deinococcus to produce carotenoids at the 20-liter scale, while a collaboration with Processium expedited the development of extraction, purification, and formulation.

The company is currently transferring the technology to SAS PIVERT, which will undertake the fermentation at commercial scale.

The first industrial batches are expected to be available in the first quarter of next year to support the commercial launch of the cosmetics ingredient in the second quarter.

DEINOVE adds that it has demonstrated the safety of Deinococcus geothermalis, the strain involved in the production process. The tests were conducted on a GRAS self-affirmation scheme and also in line with OECD guidelines.

“We are about to produce our first ingredient on an industrial scale,” says Marie Bézenger, vice president of operations at DEINOVE. “Our teams are on-site to ensure the transfer of technology and we are looking forward to seeing what comes out of the first batches. This is a first for Deinove and one of the last steps before the commercialization of our innovative ingredient.”

More on the story.